Andy E. Durham
Research Subjects
Research Interests
Andy E. Durham has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Ana Lopes
Department of Internal Medicine, Liphook Equine Hospital, Liphook, GU307JG, UK
2 shared publications - Catherine Marie McGowan
University of Liverpool image/svg+xml
2 shared publications - Julien Delarocque
Clinic for Horses, University of Veterinary Medicine , Bünteweg 9, 30559 Hannover
2 shared publications Karsten Feige
Clinic for Horses, University of Veterinary Medicine , Hannover
2 shared publicationsLaura Huber
Pathobiology Department, College of Veterinary Medicine Auburn University, Alabama, USA
2 shared publications- Melody Anne de Laat
School of Biology and Environmental Science, Queensland University of Technology, Brisbane, Queensland, Australia
2 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 40 (6)
Nociceptive thresholds and beta-endorphin concentrations in horses with pituitary pars intermedia dysfunction: a cross-sectional comparative study
Background: Increased beta-endorphin (β-END) concentrations in horses with pituitary pars intermedia dysfunction (PPID) are hypothesized to lead to increased pain tolerance of affected horses, however, alteration of nociceptive thresholds (NTs) in PPID horses has not been investigated previously. Hypothesis/Objectives: Evaluate whether NTs differ between horses with PPID and controls and whether β-END concentrations correlate with NTs. Animals: Fifty equids aged 19-32 years. Methods: Cross-sectional comparative study conducted in February 2025. The study included a PPID group (n = 24 horses) and a control group (n = 26 horses). Both groups were subjected to mechanical and thermal stimulation, and NTs were recorded. Plasma adrenocorticotropic hormone (ACTH) and β-END concentrations were quantified, and the association between β-END concentrations and NTs was analyzed. Results: Although β-END concentrations were higher in the PPID group (482 [316-735] pg/mL [geometric mean (95% confidence interval [CI])]) compared with controls (47.8 [23.0-53.4] pg/mL [geometric mean (95% CI)]; P < .001), no correlation between β-END concentrations and NTs was found. Furthermore, no significant group differences and correlations were found for mechanical (MNTs) and thermal nociceptive thresholds (TNTs). Conclusions and clinical importance: In this selected cohort of older horses without clinically relevant pain, horses with PPID did not exhibit increased NTs compared to controls. Although β-END concentrations were higher in horses with PPID, no association between β-END concentrations and NTs was identified. These findings do not support a measurable effect of increased circulating β-END concentrations on NTs in the study cohort.
- 2 November 2026
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 40 (6)
Open AccessNociceptive thresholds and beta-endorphin concentrations in horses with pituitary pars intermedia dysfunction: a cross-sectional comparative study
Background: Increased beta-endorphin (β-END) concentrations in horses with pituitary pars intermedia dysfunction (PPID) are hypothesized to lead to increased pain tolerance of affected horses, however, alteration of nociceptive thresholds (NTs) in PPID horses has not been investigated previously. Hypothesis/Objectives: Evaluate whether NTs differ between horses with PPID and controls and whether β-END concentrations correlate with NTs. Animals: Fifty equids aged 19-32 years. Methods: Cross-sectional comparative study conducted in February 2025. The study included a PPID group (n = 24 horses) and a control group (n = 26 horses). Both groups were subjected to mechanical and thermal stimulation, and NTs were recorded. Plasma adrenocorticotropic hormone (ACTH) and β-END concentrations were quantified, and the association between β-END concentrations and NTs was analyzed. Results: Although β-END concentrations were higher in the PPID group (482 [316-735] pg/mL [geometric mean (95% confidence interval [CI])]) compared with controls (47.8 [23.0-53.4] pg/mL [geometric mean (95% CI)]; P < .001), no correlation between β-END concentrations and NTs was found. Furthermore, no significant group differences and correlations were found for mechanical (MNTs) and thermal nociceptive thresholds (TNTs). Conclusions and clinical importance: In this selected cohort of older horses without clinically relevant pain, horses with PPID did not exhibit increased NTs compared to controls. Although β-END concentrations were higher in horses with PPID, no association between β-END concentrations and NTs was identified. These findings do not support a measurable effect of increased circulating β-END concentrations on NTs in the study cohort.
- Open Access
- 30 October 2026
- Published by Wiley in Equine Veterinary Education
Comparison of plasma separation techniques prior to freezing on equine immunoreactive adrenocorticotrophic hormone
Summary: Background: Pituitary pars intermedia dysfunction (PPID) is the most common endocrine disorder affecting older horses and is commonly diagnosed by measurement of basal plasma adrenocorticotrophic hormone (ACTH) concentration. Current guidelines advise that whole blood or gravity‐separated plasma samples must not be frozen prior to analysis. Objectives: The aim of this study was to determine the effect of gravity separation and specifically whether gravity‐separation prior to freezing would result in increased ACTH concentrations when compared with samples centrifuged prior to freezing. Study design: Split‐sample, repeated‐measures experimental design. Methods: Blood samples from 22 horses were subjected to four different sample preparation methods: centrifuged fresh samples, centrifuged frozen samples, gravity‐separated fresh samples and gravity‐separated frozen samples. Friedman's test with Dunn's multiple comparisons was used to make comparisons between sample preparation groups. Results: Sample separation method (centrifugation vs. gravity separation) had a significant effect on ACTH concentration ( p < 0.0001). Samples that underwent centrifugation demonstrated no significant change in ACTH concentration following freezing (median % change of 3.9%, p > 0.99). In contrast, both gravity‐separated fresh samples (median % change of 23.9%) and gravity‐separated frozen samples (median % change of 14.0%) demonstrated significantly increased ACTH concentrations when compared with the reference centrifuged fresh samples ( p < 0.0001). From a clinical perspective, two samples that would have been initially classified as non‐PPID based on basal ACTH levels in centrifuged fresh samples were subsequently classified as PPID positive following freezing of gravity‐separated samples, while a further seven samples were reclassified into the equivocal diagnostic zone. Main limitations: Small sample size and small number of PPID‐positive samples included in the study. Conclusions: These findings demonstrate that gravity‐separated samples submitted to laboratories for ACTH analysis should undergo centrifugation prior to testing and support current recommendations that gravity‐separated samples should not be frozen prior to analysis.
- 30 October 2026
- Published by Wiley in Equine Veterinary Education
Open AccessComparison of plasma separation techniques prior to freezing on equine immunoreactive adrenocorticotrophic hormone
Summary: Background: Pituitary pars intermedia dysfunction (PPID) is the most common endocrine disorder affecting older horses and is commonly diagnosed by measurement of basal plasma adrenocorticotrophic hormone (ACTH) concentration. Current guidelines advise that whole blood or gravity‐separated plasma samples must not be frozen prior to analysis. Objectives: The aim of this study was to determine the effect of gravity separation and specifically whether gravity‐separation prior to freezing would result in increased ACTH concentrations when compared with samples centrifuged prior to freezing. Study design: Split‐sample, repeated‐measures experimental design. Methods: Blood samples from 22 horses were subjected to four different sample preparation methods: centrifuged fresh samples, centrifuged frozen samples, gravity‐separated fresh samples and gravity‐separated frozen samples. Friedman's test with Dunn's multiple comparisons was used to make comparisons between sample preparation groups. Results: Sample separation method (centrifugation vs. gravity separation) had a significant effect on ACTH concentration ( p < 0.0001). Samples that underwent centrifugation demonstrated no significant change in ACTH concentration following freezing (median % change of 3.9%, p > 0.99). In contrast, both gravity‐separated fresh samples (median % change of 23.9%) and gravity‐separated frozen samples (median % change of 14.0%) demonstrated significantly increased ACTH concentrations when compared with the reference centrifuged fresh samples ( p < 0.0001). From a clinical perspective, two samples that would have been initially classified as non‐PPID based on basal ACTH levels in centrifuged fresh samples were subsequently classified as PPID positive following freezing of gravity‐separated samples, while a further seven samples were reclassified into the equivocal diagnostic zone. Main limitations: Small sample size and small number of PPID‐positive samples included in the study. Conclusions: These findings demonstrate that gravity‐separated samples submitted to laboratories for ACTH analysis should undergo centrifugation prior to testing and support current recommendations that gravity‐separated samples should not be frozen prior to analysis.
- Open Access
- 8 September 2026
- Published by Elsevier in SSRN Electronic Journal
Investigation of risk factors for hypertriglyceridaemia in horses treated with sodium glucose cotransporter-2 antagonists
Sodium-glucose co-transporter-2 antagonist (SGLT2i) drugs are used to control hyperinsulinemia in horses but are associated with development of hypertriglyceridemia. Clinical laboratory submissions were examined from 985 horses sampled within 60 days of starting SGLT2i therapy. Signalment data, drug identity and time of year were examined for association with serum triglyceride (TG) concentration post-treatment with the SGLT2i drugs canagliflozin and ertugliflozin. The study also examined associations between TG and other post-treatment markers including insulin, glucose, adrenocorticotropin (ACTH), total adiponectin and gamma-glutamyl transferase (GGT). Variables associated with higher post-treatment TG included Shetland ponies, Dartmoor ponies and canagliflozin (Shetland mean ratio 1.87, 95% CI 1.37-2.56, P<0.001; Dartmoor mean ratio 2.21, 95% CI 1.33-3.67 P=0.002; Canagliflozin mean ratio 1.23, 95% CI 1.04-1.46 P=0.018). Warmbloods had lower post-treatment TG (mean ratio 0.67, 95% CI 0.45-1.00, P=0.048). Horses with moderate TG increases (2.5-5.0 mmol/L) were more likely to be Shetland ponies (OR 2.32, 95% CI 1.21-4.45, P=0.011) and to be older (OR 1.03 95% CI 1.01-1.06, P=0.017) and less likely to be Connemara ponies (OR 0.23, 95% CI 0.06-0.84, P=0.026), Warmbloods (OR 0.12, 95% CI 0.02-1.00, P=0.049) or receiving ertugliflozin (OR 0.57, 95% CI 0.37-0.87, P=0.010). Post-treatment insulin was negatively associated with post-treatment TG (P=0.001). Shetland and Dartmoor ponies were more likely to suffer hypertriglyceridemia when treated with SGLT2i drugs, and Warmbloods appeared less likely. Some effect of older age and use of canagliflozin were also seen leading to recommendations to consider alternative dosing strategies with this drug, especially when used in high-risk breeds.
- 8 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessInvestigation of risk factors for hypertriglyceridaemia in horses treated with sodium glucose cotransporter-2 antagonists
Sodium-glucose co-transporter-2 antagonist (SGLT2i) drugs are used to control hyperinsulinemia in horses but are associated with development of hypertriglyceridemia. Clinical laboratory submissions were examined from 985 horses sampled within 60 days of starting SGLT2i therapy. Signalment data, drug identity and time of year were examined for association with serum triglyceride (TG) concentration post-treatment with the SGLT2i drugs canagliflozin and ertugliflozin. The study also examined associations between TG and other post-treatment markers including insulin, glucose, adrenocorticotropin (ACTH), total adiponectin and gamma-glutamyl transferase (GGT). Variables associated with higher post-treatment TG included Shetland ponies, Dartmoor ponies and canagliflozin (Shetland mean ratio 1.87, 95% CI 1.37-2.56, P<0.001; Dartmoor mean ratio 2.21, 95% CI 1.33-3.67 P=0.002; Canagliflozin mean ratio 1.23, 95% CI 1.04-1.46 P=0.018). Warmbloods had lower post-treatment TG (mean ratio 0.67, 95% CI 0.45-1.00, P=0.048). Horses with moderate TG increases (2.5-5.0 mmol/L) were more likely to be Shetland ponies (OR 2.32, 95% CI 1.21-4.45, P=0.011) and to be older (OR 1.03 95% CI 1.01-1.06, P=0.017) and less likely to be Connemara ponies (OR 0.23, 95% CI 0.06-0.84, P=0.026), Warmbloods (OR 0.12, 95% CI 0.02-1.00, P=0.049) or receiving ertugliflozin (OR 0.57, 95% CI 0.37-0.87, P=0.010). Post-treatment insulin was negatively associated with post-treatment TG (P=0.001). Shetland and Dartmoor ponies were more likely to suffer hypertriglyceridemia when treated with SGLT2i drugs, and Warmbloods appeared less likely. Some effect of older age and use of canagliflozin were also seen leading to recommendations to consider alternative dosing strategies with this drug, especially when used in high-risk breeds.
- 28 May 2026
- Published by Elsevier in Veterinary Clinics of North America: Equine Practice
- Vol. 42 (2) , 413-423
Prognosis of Equine Liver Diseases
- 28 May 2026
- Published by Elsevier in Veterinary Clinics of North America: Equine Practice
- Vol. 42 (2) , 413-423
Prognosis of Equine Liver Diseases
- Top Cited Papers
- 23 April 2026
- Published by Elsevier in Domestic Animal Endocrinology
- Vol. 96, 107015
Transference of diagnostic thresholds for equine plasma ACTH from the Immulite 1000 to Immulite 2000XPi and Tosoh AIA systems
- 23 April 2026
- Published by Elsevier in Domestic Animal Endocrinology
- Vol. 96, 107015
Top Cited PapersTransference of diagnostic thresholds for equine plasma ACTH from the Immulite 1000 to Immulite 2000XPi and Tosoh AIA systems
- 23 June 2025
- Published by Elsevier in Domestic Animal Endocrinology
- Vol. 93, 106959
Investigation of peptide cross reactivity in equine plasma using two adrenocorticotropic hormone immunoassays
- 23 June 2025
- Published by Elsevier in Domestic Animal Endocrinology
- Vol. 93, 106959
Investigation of peptide cross reactivity in equine plasma using two adrenocorticotropic hormone immunoassays
- Open Access
- 1 May 2025
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 39 (3) , e70089
The Seasonality of Serum Insulin Concentrations in Equids and the Association With Breed, Age, and Sex
Background: Current laboratory reference values for serum insulin concentrations do not account for seasonal fluctuations and differences associated with breed, sex, and age. Hypothesis: We hypothesized that serum insulin concentrations would differ with the season, breed, sex, and age. Animals: Laboratory records from 21 236 cases. Methods: Cases were included where basal serum insulin concentration (INS) or serum insulin concentration after administration of Karo light syrup (INSpk) was measured, along with plasma glucose, breed, age, and sex. Multivariate analysis was used to investigate a seasonal effect on serum insulin concentrations, alongside the effect of breed, age, and sex. Results: Basal serum insulin concentration in winter was significantly higher than in the other seasons (p < 0.001). Serum insulin concentration following administration of Karo light syrup in winter was significantly higher than in summer and fall (p < 0.001). The breed effect was assessed in the 9 most prevalent breeds and the donkey. Shetland ponies had significantly higher INS and INSpk than all breeds except Welsh ponies(p < 0.01). Welsh ponies had significantly higher INS than all other breeds except Shetland ponies (p < 0.01). Welsh ponies had significantly higher INSpk than all breeds (all p < 0.001), except Arabians, New Forest ponies, and Shetland ponies. Females had significantly higher INS than males (p < 0.001) and there was a positive and significant association between age and INS (est = 0.02; SE = 0.002, p < 0.001). Conclusions: Insulin concentrations are influenced by season, breed, age, and sex. This information is essential for better understanding and management of insulin dysregulation.
- 1 May 2025
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 39 (3) , e70089
Open AccessThe Seasonality of Serum Insulin Concentrations in Equids and the Association With Breed, Age, and Sex
Background: Current laboratory reference values for serum insulin concentrations do not account for seasonal fluctuations and differences associated with breed, sex, and age. Hypothesis: We hypothesized that serum insulin concentrations would differ with the season, breed, sex, and age. Animals: Laboratory records from 21 236 cases. Methods: Cases were included where basal serum insulin concentration (INS) or serum insulin concentration after administration of Karo light syrup (INSpk) was measured, along with plasma glucose, breed, age, and sex. Multivariate analysis was used to investigate a seasonal effect on serum insulin concentrations, alongside the effect of breed, age, and sex. Results: Basal serum insulin concentration in winter was significantly higher than in the other seasons (p < 0.001). Serum insulin concentration following administration of Karo light syrup in winter was significantly higher than in summer and fall (p < 0.001). The breed effect was assessed in the 9 most prevalent breeds and the donkey. Shetland ponies had significantly higher INS and INSpk than all breeds except Welsh ponies(p < 0.01). Welsh ponies had significantly higher INS than all other breeds except Shetland ponies (p < 0.01). Welsh ponies had significantly higher INSpk than all breeds (all p < 0.001), except Arabians, New Forest ponies, and Shetland ponies. Females had significantly higher INS than males (p < 0.001) and there was a positive and significant association between age and INS (est = 0.02; SE = 0.002, p < 0.001). Conclusions: Insulin concentrations are influenced by season, breed, age, and sex. This information is essential for better understanding and management of insulin dysregulation.
- Open Access
Development of a Web App to Convert Blood Insulin Concentrations among Various Immunoassays Used in Horses
The measurement of the blood insulin concentration, and comparison to cut-offs, is essential in diagnosing insulin dysregulation, a common equine endocrinopathy. However, different insulin assays provide disparate results. We aimed to ease comparison between assays by compiling original and published data into a web app to convert insulin measurements from one assay to another. Data were available for ADVIA Centaur insulin chemiluminescent immunoassay (CLIA), Beckman Coulter insulin radioimmunoassay (RIA), Immulite 1000 CLIA, Immulite 2000 CLIA, Immulite 2000 XPi CLIA, Mercodia equine insulin enzyme-linked immunosorbent assay (ELISA), and Millipore porcine insulin RIA. Linear models were fitted for 13 assay pairs using non-decreasing splines, and integrated into this app. Assay comparisons including data from several studies showed a lower performance. This indicates technical variation between laboratories, which has not been described before, but is relevant when diagnostic measurements and cut-offs are provided by different laboratories. Nevertheless, the models’ overall high performance (median r2 = 0.94; range 0.57–1.00) supports their use to interpret results from diagnostic insulin measurements when the reference assay is unavailable, and to compare values obtained from different assays.
Open AccessDevelopment of a Web App to Convert Blood Insulin Concentrations among Various Immunoassays Used in Horses
The measurement of the blood insulin concentration, and comparison to cut-offs, is essential in diagnosing insulin dysregulation, a common equine endocrinopathy. However, different insulin assays provide disparate results. We aimed to ease comparison between assays by compiling original and published data into a web app to convert insulin measurements from one assay to another. Data were available for ADVIA Centaur insulin chemiluminescent immunoassay (CLIA), Beckman Coulter insulin radioimmunoassay (RIA), Immulite 1000 CLIA, Immulite 2000 CLIA, Immulite 2000 XPi CLIA, Mercodia equine insulin enzyme-linked immunosorbent assay (ELISA), and Millipore porcine insulin RIA. Linear models were fitted for 13 assay pairs using non-decreasing splines, and integrated into this app. Assay comparisons including data from several studies showed a lower performance. This indicates technical variation between laboratories, which has not been described before, but is relevant when diagnostic measurements and cut-offs are provided by different laboratories. Nevertheless, the models’ overall high performance (median r2 = 0.94; range 0.57–1.00) supports their use to interpret results from diagnostic insulin measurements when the reference assay is unavailable, and to compare values obtained from different assays.
- Open Access
- 26 January 2023
- Published by Wiley in Equine Veterinary Journal
- Vol. 55 (6) , 1003-1011
Association between insulin dysregulation and adrenocorticotropic hormone in aged horses and ponies with no clinical signs of pituitary pars intermedia dysfunction
Background: High concentrations of adrenocorticotropic hormone (ACTH) are used as an indicator of pituitary pars intermedia dysfunction (PPID), but other factors that may influence ACTH need to be understood, if diagnostic reference ranges for ACTH are to be used with confidence. Insulin dysregulation (ID) could be one such factor, as insulin affects pituitary hormones in other species. Objectives: To test the hypothesis that a relationship exists between high insulin and high ACTH in aged (>15‐year‐old) animals with no clinical signs of PPID. Study design: A cohort study. Methods: Thirteen horses and eleven ponies (17–25 years‐old; mares and geldings) were clinically examined for signs of PPID in the spring (November 2020) and autumn (April 2021). On the same day, blood samples were taken before and 2 h after an oral glucose test (OGT). Concentrations of insulin, glucose, ACTH and cortisol were measured. Results: There was no association between ACTH and cortisol. However, there was a positive linear correlation between ACTH and post‐OGT (insulin in the autumn ( r = 0.427, p = 0.04). Two horses and six ponies had ACTH above the cut‐off value for PPID diagnosis, and of these eight animals, six also had insulin concentrations above the cut‐off value for ID. Main limitations: The cohort was small and thyrotropin‐releasing hormone (TRH) stimulation tests were not performed. Conclusions: In autumn, high ACTH was associated with ID, when no clinical signs of PPID were present. Because ACTH is used in PPID diagnosis, further work is required to understand this interaction.
- 26 January 2023
- Published by Wiley in Equine Veterinary Journal
- Vol. 55 (6) , 1003-1011
Open AccessAssociation between insulin dysregulation and adrenocorticotropic hormone in aged horses and ponies with no clinical signs of pituitary pars intermedia dysfunction
Background: High concentrations of adrenocorticotropic hormone (ACTH) are used as an indicator of pituitary pars intermedia dysfunction (PPID), but other factors that may influence ACTH need to be understood, if diagnostic reference ranges for ACTH are to be used with confidence. Insulin dysregulation (ID) could be one such factor, as insulin affects pituitary hormones in other species. Objectives: To test the hypothesis that a relationship exists between high insulin and high ACTH in aged (>15‐year‐old) animals with no clinical signs of PPID. Study design: A cohort study. Methods: Thirteen horses and eleven ponies (17–25 years‐old; mares and geldings) were clinically examined for signs of PPID in the spring (November 2020) and autumn (April 2021). On the same day, blood samples were taken before and 2 h after an oral glucose test (OGT). Concentrations of insulin, glucose, ACTH and cortisol were measured. Results: There was no association between ACTH and cortisol. However, there was a positive linear correlation between ACTH and post‐OGT (insulin in the autumn ( r = 0.427, p = 0.04). Two horses and six ponies had ACTH above the cut‐off value for PPID diagnosis, and of these eight animals, six also had insulin concentrations above the cut‐off value for ID. Main limitations: The cohort was small and thyrotropin‐releasing hormone (TRH) stimulation tests were not performed. Conclusions: In autumn, high ACTH was associated with ID, when no clinical signs of PPID were present. Because ACTH is used in PPID diagnosis, further work is required to understand this interaction.